Your browser doesn't support javascript.
loading
A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment.
Boulant, Thibaud; Jousset, Agnès B; Bonnin, Rémy A; Barrail-Tran, Aurélie; Borgel, Adrien; Oueslati, Saoussen; Naas, Thierry; Dortet, Laurent.
  • Boulant T; EA7361 "Structure, dynamic, function and expression of broad spectrum ß-lactamases", Paris-Sud University, Paris Saclay University, LabEx Lermit, Le Kremlin-Bicêtre, France.
  • Jousset AB; Paris-Sud University, Paris Saclay University, Faculty of Medicine, Le Kremlin-Bicêtre, France.
  • Bonnin RA; EA7361 "Structure, dynamic, function and expression of broad spectrum ß-lactamases", Paris-Sud University, Paris Saclay University, LabEx Lermit, Le Kremlin-Bicêtre, France.
  • Barrail-Tran A; Paris-Sud University, Paris Saclay University, Faculty of Medicine, Le Kremlin-Bicêtre, France.
  • Borgel A; Department of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique - Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Oueslati S; EA7361 "Structure, dynamic, function and expression of broad spectrum ß-lactamases", Paris-Sud University, Paris Saclay University, LabEx Lermit, Le Kremlin-Bicêtre, France.
  • Naas T; Paris-Sud University, Paris Saclay University, Faculty of Medicine, Le Kremlin-Bicêtre, France.
  • Dortet L; Department of Pharmacy, Bicêtre Hospital, Assistance Publique - Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
Antimicrob Agents Chemother ; 63(12)2019 09 09.
Article en En | MEDLINE | ID: mdl-31636072